ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
11/7/2024 10:51:07 AM | Chg. -0.050 | Volume | Bid10:51:07 AM | Ask10:51:07 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
102.100EUR | -0.05% | - Turnover: - |
102.100Bid Size: - | 103.050Ask Size: - | 20.43 bill.EUR | - | - |
Assets
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 2,062.6000 | 2,037.9000 | 2,038.6000 | 2,015.4000 | 2,077.4000 | ||||||
Intangible Assets | 8,746.3000 | 8,785.4000 | 8,353.4000 | 7,684.6000 | 7,257.6000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 21,356.6000 | 22,020.8000 | 21,449.2000 | 19,699.4000 | 19,914.8000 | ||||||
Inventories | 2,254.1000 | 1,959.4000 | 2,081.8000 | 2,256.5000 | 2,385 | ||||||
Accounts Receivable | 1,446.5000 | 1,604.4000 | 1,494.6000 | 1,275.8000 | 1,363.9000 | ||||||
Cash and Cash Equivalents | 1,459.3000 | 634.1000 | 524.4000 | 542.8000 | 617.9000 | ||||||
Current Assets | 5,862.9000 | 4,663.6000 | 4,515.3000 | 4,427.4000 | 4,723.9000 | ||||||
Total Assets | 27,219.5000 | 26,684.4000 | 25,964.5000 | 24,126.8000 | 24,638.7000 |
Liabilities
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 284.8000 | 364.5000 | 330.2000 | 362.6000 | 400.9000 | ||||||
Long-term debt | 11,556.3000 | 10,665.8000 | 8,917.5000 | 8,413.7000 | 6,721.4000 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 3,150.2000 | 3,030.9000 | 1,101.5000 | 999.5000 | 840.1000 | ||||||
Liabilities | 17,330.1000 | 17,014.5000 | 14,229 | 12,850.7000 | 12,245.9000 | ||||||
Share Capital | 3 | 3.1000 | 3.1000 | 3.1000 | 3.1000 | ||||||
Total Equity | 9,889.4000 | 9,669.9000 | 11,735.5000 | 11,276.1000 | 12,392.8000 | ||||||
Minority Interests | 1.5000 | 1 | -.3000 | 4.8000 | 4.7000 | ||||||
Total liabilities equity | 27,219.5000 | 26,684.4000 | 25,964.5000 | 24,126.8000 | 24,638.7000 |
Income Statement
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5,997.8000 | 7,683.9000 | 7,824.1000 | 7,932.9000 | 7,982.2000 | ||||||
Depreciation (total) | 337.4000 | 565.9000 | 603.9000 | 595.9000 | 584.3000 | ||||||
Operating Result | 467.3000 | 825.9000 | 808.2000 | 33.8000 | 1,137.5000 | ||||||
Interest Income | 9.4000 | 2.9000 | 2.2000 | -289.3000 | -226.9000 | ||||||
Income Before Taxes | 153.2000 | 399.6000 | 464.6000 | -271.1000 | 905.8000 | ||||||
Income Taxes | 7 | 95 | -1,348.8000 | 108.2000 | -225.7000 | ||||||
Minority Interests Profit | -.8000 | -1.3000 | -.4000 | -.1000 | -.1000 | ||||||
Net Income | 147 | 305.9000 | 1,813.8000 | -379.2000 | 1,131.6000 |
Per Share
Cash Flow
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 816.7000 | 1,632.2000 | 1,582.3000 | 1,747.4000 | 1,585.8000 | ||||||
Cash Flow from Investing Activities | -7,557.9000 | -1,691.5000 | -510.8000 | -416.6000 | -729.3000 | ||||||
Cash Flow from Financing | 7,139.8000 | -743.2000 | -1,210.5000 | -1,302.2000 | -779.9000 | ||||||
Decrease / Increase in Cash | 376 | -825.2000 | -109.7000 | 18.4000 | 75.1000 | ||||||
Employees | 17,500 | 18,500 | 18,200 | 19,000 | 19,900 |